unknown
Stage
2020
Founded
3
Investors
About
Iambic Therapeutics uses AI-driven technologies combined with high-throughput experimentation to discover and develop optimized drug candidates, focusing on transforming undruggable targets and advancing first-in-class therapies for cancer.
Explore Iambic Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.